Abdelaal MA 2021 Lamivudine: An antiviral drug with high risk factor for selection of resistance in HBV patients. Rec. Pharmaceut. Biomed. Sci. 5 81–84

Google Scholar 

Agustiningsih A, Rasyak MR, Jayanti S, et al. 2024 The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates. Explor. Target Antitumour Ther. 5 120–134

CAS  Google Scholar 

Ariumi Y 2023 Hepatitis B virus polymerase restricts LINE-1 mobility. Gene 850 146943

CAS  PubMed  Google Scholar 

Chuang YC, Tsai KN and Ou JJ 2022 Pathogenicity and virulence of hepatitis B virus. Virulence 13 258–296

CAS  PubMed  PubMed Central  Google Scholar 

Colaluca IN, Tosoni D, Nuciforo P, et al. 2008 NUMB controls p53 tumour suppressor activity. Nature 451 76–80

CAS  PubMed  Google Scholar 

De Mitri MS, Cassini R, Morsica G, et al. 2006 Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma. J. Viral Hepat. 13 574–581

PubMed  Google Scholar 

DiMattia MA, Watts NR, Stahl SJ, et al. 2013 Antigenic switching of hepatitis B virus by alternative dimerisation of the capsid protein. Structure 21 133–142

CAS  PubMed  Google Scholar 

Dishlers A, Petrovskis I, Skrastina D, et al. 2023 PreS1 containing HBc VLPs for the development of a combined therapeutic/prophylactic hepatitis B vaccine. Microorganisms 11 972

CAS  PubMed  PubMed Central  Google Scholar 

Günther S, Paulij W, Meisel H, et al. 1998 Analysis of hepatitis B virus populations in an interferon-alpha-treated patients exhibit predominant mutations in the C-gene and changes e-antigenicity. Virology 244 146–160

PubMed  Google Scholar 

Hayer J, Jadeau F, Deléage G, et al. 2013 HBVdb: a knowledge database for hepatitis B virus. Nucleic Acids Res. 41 D566–D570

CAS  PubMed  Google Scholar 

Honda T 2016 Links between human LINE-1 retrotransposons and hepatitis virus-related hepatocellular carcinoma. Front. Chem. 4 21

PubMed  PubMed Central  Google Scholar 

Höner Zu Siederdissen C and Cornberg M 2016 Management of HBV and HBV/HDV-associated liver cirrhosis. Visc. Med. 32 86–94

PubMed  PubMed Central  Google Scholar 

Jiang SZ, Gao ZY, Li T, et al. 2009 T3098C and T53C mutations of HBV genotype C is associated with progression of HBV infection. Biomed. Environ. Sci. 22 511–517

CAS  PubMed  Google Scholar 

Kaplan W and Littlejohn TG 2001 Swiss-PDB Viewer (Deep View). Brief Bioinform. 2 195–197

CAS  PubMed  Google Scholar 

Kim H, Ko C, Lee JY, et al. 2021 Current progress in the development of hepatitis B virus capsid assembly modulators: chemical structure, mode of action and efficacy. Molecules 26 7420

CAS  PubMed  PubMed Central  Google Scholar 

Kim S, Chen J, Cheng T, et al. 2023 PubChem 2023 update. Nucleic. Acids. Res. 51 D1373–D1380

PubMed  Google Scholar 

Kuduk SD, DeRatt LG, Stoops B, et al. 2022 Diazepinone HBV capsid assembly modulators. Bioorg. Med. Chem. Lett. 72 128823

CAS  PubMed  Google Scholar 

Kuhns MC, Holzmayer V, Anderson M, et al. 2021 Molecular and serological characterisation of hepatitis B virus (HBV)-positive samples with very low or undetectable levels of HBV surface antigen. Viruses 13 2053

CAS  PubMed  PubMed Central  Google Scholar 

Kumar K, Kumar M, Rahaman SH, et al. 2011 Distribution of hepatitis B virus genotypes among healthy blood donors in the eastern part of North India. Asian J. Transfus. Sci. 5 144–149

PubMed  PubMed Central  Google Scholar 

Langley DR, Walsh AW, Baldick CJ, et al. 2007 Inhibition of hepatitis B virus polymerase by entecavir. J. Virol. 81 3992–4001

CAS  PubMed  PubMed Central  Google Scholar 

Lazarevic I, Banko A, Miljanovic D, et al. 2024 Hepatitis B surface antigen isoforms: Their clinical implications, utilisation in diagnosis, prevention and new antiviral strategies. Pathogens 13 46

CAS  PubMed  PubMed Central  Google Scholar 

Lehmann F, Slanina H, Roderfeld M, et al. 2023 A novel insertion in the hepatitis B virus surface proteins leading to hyperglycosylation cause diagnostic and immune escape. Viruses 15 838

CAS  PubMed  PubMed Central  Google Scholar 

Li T, Chen H, Sun L, et al. 2022 Dating the origin and dispersal of global hepatitis B virus genotype C in humans. Drug Discov. Ther. 16 85–92

Liu D, Cui L, Wang Y, et al. 2016 Hepatitis B e antigen and its precursors promote the progress of hepatocellular carcinoma by interacting with NUMB and decreasing p53 activity. Hepatology 64 390–404

Liu Z, Zhang Y, Xu M, et al. 2021 Distribution of hepatitis B virus genotypes and subgenotypes: A meta-analysis. Medicine 100 e27941

CAS  PubMed  PubMed Central  Google Scholar 

Lumley SF, Delphin M, Mokaya JF, et al. 2023 A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) genotypic resistance in people treated with entecavir or tenofovir. J. Clin. Virol. 174 105711

Google Scholar 

McNaughton AL, Revill PA, Littlejohn M, et al. 2020 Analysis of genomic-length HBV sequences to determine genotype and subgenotype reference sequences. J. Gen. Virol. 101 271–283

CAS  PubMed  PubMed Central  Google Scholar 

Milich DR, McLachlan A, Raney AK, et al. 1991 Autoantibody production in hepatitis B e antigen transgenic mice elicited with a self T-cell peptide and inhibited with nonself peptides. Proc. Natl. Acad. Sci USA 88 4348–4352

CAS  PubMed  PubMed Central  Google Scholar 

Mirdita M, Schütze K, Moriwaki Y, et al. 2022 ColabFold: Making protein folding accessible to all. Nat. Methods 19 679–682

CAS  PubMed  PubMed Central  Google Scholar 

Morris GM, Goodsell DS, Halliday RS, et al. 1998 Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 19 1639–1662

CAS  Google Scholar 

Ou G, Zhao C, Deng J, et al. 2023 Host sex disparity and viral genotype dependence of the glycosylation level of small hepatitis B surface protein in patients with HBeAg-positive chronic hepatitis B. Virol. J. 20 159

CAS  PubMed  PubMed Central  Google Scholar 

Padarath K, Deroubaix A and Kramvis A 2023 The complex role of HBeAg and its precursors in the pathway to hepatocellular carcinoma. Viruses 15 857

Paraskevis D, Magiorkinis G, Magiorkinis E, et al. 2013 Dating the origin and dispersal of hepatitis B virus infection in humans and primates. Hepatology 57 908–916

Pettersen EF, Goddard TD, Huang CC, et al. 2004 UCSF Chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 25 1605–1612

Rodrigues CHM, Pires DEV and Ascher DB 2021 DynaMut2: Assessing changes in stability and flexibility upon single and multiple point missense mutations. Protein Sci. 30 60–69

Salfeld J, Pfaff E, Noah M, et al. 1989 Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus. J. Virol. 63 798–808

Schlicksup CJ, Laughlin P, Dunkelbarger S, et al. 2020 Local stabilization of subunit-subunit contacts causes global destabilization of hepatitis B virus capsids. ACS Chem. Biol. 15 1708–1717

Senthilazhagan K, Sakthimani S, Kallanja D, et al. 2023 SARS-CoV-2: analysis of the effects of mutations in non-structural proteins. Arch. Virol. 168 186

Singh A, Copeland MM, Kundrotas PJ, et al. 2023 GRAMM web server for protein docking. Methods Mol. Biol. 2714 101–112

Sivasudhan E, Blake N, Lu Z, et al. 2022 Hepatitis B viral protein HBx and the molecular mechanisms modulating the hallmarks of hepatocellular carcinoma: A comprehensive review. Cells 11 741

Soussan P, Garreau F, Zylberberg H, et al. 2000 In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA. J. Clin. Invest. 105 55–60

Tang S, Murakami T, Agresta BE, et al. 2001 Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells. J. Virol. 75 9357–9366

van Hemert FJ, Berkhout B and Zaaijer HL 2014 Differential binding of tenofovir and adefovir to reverse transcriptase of hepatitis B virus. PLoS One 9 e106324

Velkov S, Ott JJ, Protzer U, Michler T, et al. 2018 The global hepatitis B virus genotype distribution approximated from available genotyping data. Genes 9 495

Wang F, Song H, Xu F, et al. 2023 Role of hepatitis B virus non-structural protein HBx on HBV rep-lication, interferon signalling, and hepatocarcinogenesis. Front. Microbiol. 14 1322892

Wang H, Wang M, Huang J, et al. 2020 Novel hepatitis B virus surface antigen mutations associated with occult genotype B hepatitis B virus infection affect HBsAg detection. J. Viral Hepat. 27 915–921

Waterhouse A, Bertoni M, Bienert S, et al. 2018 SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46 W296–W303

Wishart DS, Knox C, Guo AC, et al. 2008 DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 36 D901–D906

Wynne SA, Crowther RA and Leslie AG 1999 The crystal structure of the human hepatitis B virus capsid. Mol. Cell. 3 771–780

Yu Y, Pandeya DR, Liu ML, et al. 2010 Expression and purification of a functional human hepatitis B virus polymerase. World J. Gastroenterol. 16 5752–5758

Zhang X, Tang Y, Wu M, et al. 2022 The origin of capsid-derived immune complexes and their impact on HBV-induced liver diseases. Viruses 14 2766

CAS  PubMed  PubMed Central  Google Scholar 

Zheng CL, Fu YM, Xu ZX, et al. 2019 Hepatitis B virus core protein dimer-dimer interface is critical for viral replication. Mol. Med. Rep. 19 262–270

CAS  PubMed  Google Scholar 

Zoulim F, Zlotnick A, Buchholz S, et al. 2022 Nomenclature of HBV core protein-targeting antivirals. Nat. Rev. Gastroenterol. Hepatol. 19 748–750

CAS  PubMed  PubMed Central  Google Scholar